J1945 Lepirudin Injection HCPCS Reimbursement

HCPCS Level II code J1945 denotes a 50 mg injectable dose of lepirudin, an anticoagulant used for parenteral antithrombotic therapy. This code matters nationally because it identifies a specialty injectable medication administered in outpatient infusion suites, hospital inpatient units, and other sites that deliver parenteral anticoagulation. Accurate coding of J1945 affects clinical documentation, medication inventory tracking, and claims processing for high-cost, specialty injectable agents.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for lepirudin use, common sites of service where billing occurs, and what to expect in claims submission for this HCPCS Level II code. The publication summarizes available benchmarks and reimbursement considerations when present, flags common coding issues, and outlines policy or billing workflow factors that influence clean claims and payment for injectable anticoagulants.

The report is designed for coding professionals, revenue cycle managers, and clinical leaders seeking concise guidance on the role of J1945 in billing and operational workflows, along with national payer considerations and practical context for where and how this service is typically provided.

Billing Code Overview

HCPCS Level II code J1945 describes an injectable medication: Injection, lepirudin, 50 mg. The service type is injectable anticoagulant/antithrombotic therapy administered by parenteral injection. The typical site of service for this code is outpatient infusion or inpatient hospital setting, including specialty infusion centers where parenteral anticoagulant therapy is provided.

Data not available in the input.

Clinical Context

A typical patient is an adult with confirmed or suspected heparin-induced thrombocytopenia (HIT) or a patient requiring anticoagulation when heparin is contraindicated. The patient presents to an inpatient ward, intensive care unit, or anticoagulation clinic after laboratory testing or clinical assessment suggests HIT (for example, a falling platelet count and new thrombosis) or when planned procedures require temporary anticoagulation with a direct thrombin inhibitor. The clinical workflow includes confirmation of indication, review of baseline coagulation studies and renal function, ordering of the medication, preparation of J1945 (injection, lepirudin, 50 mg), informed consent for risks including bleeding, administration by a qualified clinician or registered nurse, and post-dose monitoring of bleeding signs and hemoglobin/hematocrit and, if used, anticoagulation laboratory parameters. Dosing frequency and duration are determined by the treating physician and adjusted for renal function. Documentation includes indication, dose and lot number of J1945, route of administration, site of injection, patient tolerance, and monitoring plan.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When lepirudin administration requires substantially greater physician work due to complexity or complications such as difficult vascular access or concurrent procedures.

Taxonomy Code	Specialty	Notes
`2080P0807X`	Hematology	Hematologists manage HIT diagnosis and direct alternative anticoagulant therapy such as lepirudin.
`208000000X`	Internal Medicine	Hospitalists and internists commonly order and manage inpatient anticoagulation therapy.
`363LF0000X`	Vascular Medicine	Vascular medicine specialists manage thrombosis and may direct parenteral direct thrombin inhibitor use.
`207R00000X`	Emergency Medicine	Emergency physicians may initiate lepirudin for acute suspected HIT prior to inpatient transfer.
`363A00000X`	Clinical Pharmacology / Anticoagulation Management	Pharmacists and anticoagulation specialists provide dosing review, monitoring, and education.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D75.82`	Heparin-induced thrombocytopenia (HIT)	Primary indication for use of lepirudin as an alternative anticoagulant when heparin is contraindicated.
`I82.40`	Acute embolism and thrombosis of unspecified deep veins of lower extremity	Thrombotic event in the setting of HIT where direct thrombin inhibitors like lepirudin are used.
`I26.99`	Other pulmonary embolism without acute cor pulmonale	Pulmonary embolism where heparin is contraindicated and lepirudin serves as anticoagulation.
`I74.3`	Embolism and thrombosis of arteries of lower extremity	Arterial thrombosis management when heparin cannot be used.
`T45.515A`	Adverse effect of heparin, initial encounter	Used when documenting adverse reaction to heparin that prompts switch to lepirudin.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used to report clinician or nurse administration of a parenteral anticoagulant dose when applicable by payer rules.
`36415`	Collection of venous blood by venipuncture	Performed before or after dosing to obtain baseline and monitoring labs (CBC, coagulation studies, renal function).
`93000`	Electrocardiogram, routine EKG with at least 12 leads; with interpretation and report	May be obtained in unstable patients or when monitoring for cardiac effects in critically ill patients receiving anticoagulation.
`99223`	Initial hospital care, typically 70 minutes or more	Used for inpatient critical or complex admission where initiation of alternative anticoagulation with `J1945` is part of initial management.
`96360`	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	If intravenous access and infusion support are required in the administration workflow alongside bolus dosing.

OpenPayer

Summary & Overview

HCPCS J1945: Injection, lepirudin, 50 mg